Enjoy this article it’s long and interesting! (Compelling/amazing results in 160 patents ph2, then forced into an adaptive arm trial 3000 patients)
How a cheap antidepressant emerged as a promising Covid-19 treatment Most Covid-19 drug treatments that have been included in trials haven’t panned out. A large new study suggests fluvoxamine might be different.
This should educate about 95% of you on this board to reality. Ipix still has an amazing opportunity but as I’ve said they need to license their drug post ph2 or even run the risk of quick expulsion from a gov ph3. Gonna need 2000 in a ph3 to be taken seriously—will have to be a government or partner trial due to costs and speed for 2000 ish patients. I’m certain ipix already has a partner or gov trial teed up to start / sign deal 30’days after. Wes release given they have had 1 year to arrange this!
News 
Market Data 
Discover 
